Amn Healthcare Stock Story

As many rational traders are trying to avoid healthcare space, it makes sense to outline Amn Healthcare Services a little further and understand how it stands against Acadia Healthcr and other similar entities. We are going to inspect some of the competitive aspects of both Amn Healthcare and Acadia.
Published over three months ago
View all stories for Amn Healthcare | View All Stories
Is Acadia more volatile than Amn Healthcare Services (NYSE:AMN)?
By analyzing existing primary indicators between Amn Healthcare and Acadia, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Acadia with a short position in Amn Healthcare. Check out our pair correlation module for more information.

Let's begin by analyzing the assets.
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amn Healthcare has an asset utilization ratio of 369.14 percent. This suggests that the company is making $3.69 for each dollar of assets. An increasing asset utilization means that Amn Healthcare Services is more efficient with each dollar of assets it utilizes for everyday operations.

How important is Amn Healthcare's Liquidity

Amn Healthcare financial leverage refers to using borrowed capital as a funding source to finance Amn Healthcare Services ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Amn Healthcare financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Amn Healthcare's total debt and its cash.

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Amn Healthcare, but it might be worth checking our own buy vs. sell analysis

Exercise or conversion by R Harris of 21 shares of Amn Healthcare subject to Rule 16b-3

Legal trades by Amn Healthcare insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Amn Healthcare insider trading alert for exercise of common stock by R Harris, the corporate stakeholder, on 21st of April 2022. This event was filed by Amn Healthcare Services I with SEC on 2022-04-22. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking it down

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Lets now take a look at Amn Healthcare revenue. Based on the latest financial disclosure, Amn Healthcare Services reported 3.25 B of revenue. This is 57.39% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The revenue for all United States stocks is 65.55% higher than that of the entity. As for Acadia Healthcr we see revenue of 2.26 B, which is much higher than that of the Medical Care Facilities

Amn Healthcare3.25 Billion
Acadia2.26 Billion
3.2 B
Amn Healthcare
2.3 B

Our perspective of the latest Amn Healthcare rise

The standard deviation is down to 3.0 as of today. Amn Healthcare Services exhibits very low volatility with skewness of 0.67 and kurtosis of 4.18. However, we advise investors to further study Amn Healthcare Services technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Amn Healthcare's stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Amn Healthcare's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Amn Healthcare Implied Volatility

Amn Healthcare's implied volatility exposes the market's sentiment of Amn Healthcare Services stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Amn Healthcare's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Amn Healthcare stock will not fluctuate a lot when Amn Healthcare's options are near their expiration.

Our Final Takeaway

Whereas some other companies under the medical care facilities industry are still a bit expensive, Amn Healthcare may offer a potential longer-term growth to institutional investors. In closing, as of the 19th of February 2022, we believe Amn Healthcare is currently undervalued. It follows the market closely and projects low chance of distress in the next two years. Our actual 90 days buy-or-sell advice on the company is Strong Buy.

Editorial Staff

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Amn Healthcare Services. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to